Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The European Commission has granted marketing authorization for the use of Johnson & Johnson's product Ionsys, a patient controlled patch for the management of acute moderate to severe post-operative pain.
Subscribe to our email newsletter
The patch was developed by J&J’s subsidiary, Alza Corporation, which is now working on manufacturing processes with a launch expected in 2007.
Ionsys is a compact, non-invasive, self-contained and pre-programmed analgesic system. Designed to adhere to a patient’s upper arm or chest, the system uses a low level electrical current to deliver the medication directly through the skin and into the bloodstream with the push of a button.
Ionsys will be marketed in the European Union by Janssen-Cilag companies. The product is currently under review by the FDA, and upon approval, Ortho-McNeil will market the product in the US.